Company:

News and Publications

FOR IMMEDIATE RELEASE

For more information contact:
Stephanie Stiles, Director of Marketing
phone: 781.273.5480
sstiles@putassoc.com

Domenick Bertelli Promoted to Putnam Associates' Partner
Recognition for significant value brought to firm's biopharmaceutical clients

January 1, 2009 -- Putnam Associates, a Boston-based strategy consulting firm serving the pharmaceutical and biotechnology industries globally, is pleased to announce that Domenick Bertelli has been promoted to Partner.

Mr. Bertelli joined Putnam Associates in 2003 and has advised pharmaceutical, biotech, and medical device clients on growth strategies, therapeutic area strategies, and pricing and reimbursement. He has specialized in studies that leverage significant quantitative analysis, which often involve primary research, and which usually include extensive synthesis to generate strategic recommendations. His dozen clients have encompassed three of the world's top five pharmaceutical companies, several leading biotechs, and one of the fastest growing therapeutic device companies. His experience comprises both U.S. and global studies in several therapeutic areas — oncology, immunology, endocrinology, CNS, GI, cardiology, pulmonology, and women's health. While working on portfolios and products that include both established category leaders and niche products, he has also had the opportunity to counsel several of the most prominent and successful new launches in recent years.

Prior to joining Putnam, Domenick was an Engagement Manager in McKinsey & Company's New York office, where he was a member of the Pharmaceutical and Medical Products, High Tech, and Corporate Finance practices. Before McKinsey, he worked on Wall Street as an investment banker at BTAlex.Brown, conducted operations research as part of MIT's Lean Aerospace Initiative, and supported non-profits focused on economic development in a half dozen states.

He earned an AB degree in Government from Harvard University in 1991, and an MBA in New Product and Venture Development from the MIT Sloan School of Management in 1999.

"We are pleased to welcome a person of Domenick's caliber into the partnership. We recognize Domenick for the exceptional value he has created for Putnam clients in his six-year tenure," remarked Kevin J. Gorman, Managing Partner.

Bertelli noted, "I am excited to be a member of Putnam's talented partnership and hope to continue contributing as a leader in the firm. I look forward to new challenges in building and expanding our consulting practice as the biopharmaceutical and device industries continue to evolve."

Putnam Associates (www.putassoc.com) is a strategy consulting firm headquartered in Boston, founded in 1988, advising the pharmaceutical, biotechnology, diagnostics, and medical device industries on a global basis. Two decades of experience and focus in their industries enable them to create significant value for their clients. Creative and disciplined strategy development processes blend with deep market knowledge for one purpose: to help their clients succeed. The company's partnership includes: Kevin J. Gorman, Managing Partner (BA, Boston College; MBA, Harvard Business School); John A. Gordon, Partner (BA, summa cum laude, Tufts University; MBA, Harvard Business School); Eric C. Auger, Partner (BA, Providence College; MA, Boston University); and Domenick Bertelli, Partner (AB, Harvard University; MBA, MIT Sloan School of Management); Remco op den Kelder, Partner (BA, Fontys University; MSc, University of Strathclyde); Paul Bogorad, Partner (BA, Swarthmore College; MBA, Columbia Business School; Ph.D., Princeton University).

###